PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-08-20

Date Title Company
20-Aug-2020 Facts & Factors Predicts that by 2026 the Size of the Bipolar Disorder Therapeutics Market Grow at CAGR of 2.0% and Reach USD 4,384.2 Million CDN Newswire
20-Aug-2020 Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD Verona Pharma plc
20-Aug-2020 Emergex and Bio-Manguinhos/Fiocruz Elucidate T Cell Epitopes Produced by Commercial Yellow Fever Vaccine Emergex Vaccines Holding Limited
20-Aug-2020 New links found between diabetes blood markers and Alzheimer’s disease pathology University of Eastern Finland
20-Aug-2020 Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease Tiziana Life Sciences plc
20-Aug-2020 Intravacc's candidate RSV vaccine demonstrates safety in phase I trial Intravacc
20-Aug-2020 Facts & Factors Predicts that by 2026 the Size of the Urinary Tract Infection Diagnosis Market Will Reach USD 2,000 Million CDN Newswire
20-Aug-2020 Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use AstraZeneca
20-Aug-2020 The UK’s biggest innovation network extends its problem-solving prowess to “change the world” KTN
20-Aug-2020 Facts & Factors Predicts that by 2026 the Size of the Peptide Therapeutics Market Grow by 8.5% and Reach USD 42.5 Billion CDN Newswire
20-Aug-2020 Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology Amarin Corporation plc
20-Aug-2020 Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology Amarin Corporation plc
20-Aug-2020 Facts & Factors Predicts that by 2026 the Size of the Antiviral Drug Resistance Market Grow by 6.5% and Reach USD 4,000 Million CDN Newswire
20-Aug-2020 Kiadis collaborates with premier Dutch institutions to apply K-NK-cell technology for the development of a novel COVID-19 therapy Kiadis Pharma N.V.
20-Aug-2020 Thermo Fisher Scientific and Hengrui Therapeutics, Inc. to Co-Develop Companion Diagnostic for Cancer Thermo Fisher Scientific
20-Aug-2020 George Clinical Scientific Leadership Adds Hypertension and Cardiovascular Researcher Professor Alta Schutte George Clinical
20-Aug-2020 Liquidia Announces Chief Financial Officer Transition Liquidia
20-Aug-2020 ViiV Healthcare announces data demonstrating the feasibility of Dovato (dolutegravir/lamivudine) as a treatment option for rapid initiation after diagnosis in adults with HIV-1 ViiV Healthcare
20-Aug-2020 E-Prescribing Solutions Market 2020-Global Industry Analysis by Size, Share, COVID-19 Impact Analysis, Trends,Growth Application and Key Players-Allscripts Healthcare, LLC,Cerner, DrFirst, eClinicalWorks, McKesson, Surescripts CDN Newswire
20-Aug-2020 ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines ATAI Life Sciences